These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12193977)

  • 1. [Initiation of oral anticoagulant treatment: comparison between different dosage regimens of warfarin and phenprocoumon].
    Kemkes-Matthes B; Matzdorff A; Heidt M; Winkler L; Bernardo A; Bernardo A
    Hamostaseologie; 2002 May; 22(2):47-51. PubMed ID: 12193977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of oral anticoagulant therapy in patients who perform self management: warfarin versus phenprocoumon.
    Jensen CF; Christensen TD; Maegaard M; Hasenkam JM
    J Thromb Thrombolysis; 2009 Oct; 28(3):276-81. PubMed ID: 18827976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Warfarin and phenprocoumon: experience of an outpatient anticoagulation clinic].
    Leiria TL; Pellanda L; Miglioranza MH; Sant'anna RT; Becker LS; Magalhães E; Lima GG
    Arq Bras Cardiol; 2010 Jan; 94(1):41-5. PubMed ID: 20414525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between maintenance dosages of three vitamin K antagonists: acenocoumarol, warfarin and phenprocoumon.
    van Leeuwen Y; Rosendaal FR; van der Meer FJ
    Thromb Res; 2008; 123(2):225-30. PubMed ID: 18407321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self- versus conventional management of oral anticoagulant therapy: effects on INR variability and coumarin dose in a randomized controlled trial.
    Christensen TD; Maegaard M; Sørensen HT; Hjortdal VE; Hasenkam JM
    Am J Cardiovasc Drugs; 2007; 7(3):191-7. PubMed ID: 17610346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a simple dosage scheme for transition from phenprocoumon to warfarin in oral anticoagulation.
    Kristiansen C; Lassen JF; Dahler-Eriksen BS; Dahler-Eriksen K; Larsen TB; Brandslund I
    Thromb Res; 2000 Apr; 98(2):157-63. PubMed ID: 10713317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Computer aided dosage management of phenprocoumon anticoagulation therapy. Clinical validation].
    Dissmann R; Cromme LJ; Salzwedel A; Taborski U; Kunath J; Gäbler F; Heyne K; Völler H
    Hamostaseologie; 2014; 34(3):226-32. PubMed ID: 24888786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Warfarin therapy: evolving strategies in anticoagulation.
    Horton JD; Bushwick BM
    Am Fam Physician; 1999 Feb; 59(3):635-46. PubMed ID: 10029789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
    D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
    Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initiation of warfarin therapy in elderly medical inpatients: a safe and accurate regimen.
    Siguret V; Gouin I; Debray M; Perret-Guillaume C; Boddaert J; Mahé I; Donval V; Seux ML; Romain-Pilotaz M; Gisselbrecht M; Verny M; Pautas E
    Am J Med; 2005 Feb; 118(2):137-42. PubMed ID: 15694897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtherapeutic oral anticoagulant therapy: frequency and risk factors.
    Rombouts EK; Rosendaal FR; van der Meer FJ
    Thromb Haemost; 2009 Mar; 101(3):552-6. PubMed ID: 19277419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
    Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
    Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cohort study on the quality of oral anticoagulation therapy in chronic haemodialysis patients treated with phenprocoumon.
    Praehauser C; Grandjean R; Steiger J; Mayr M
    Swiss Med Wkly; 2013; 143():w13730. PubMed ID: 23297022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
    Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
    Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased anticoagulant activity of warfarin used in combination with doxifluridine.
    Nakajima M; Genda T; Suehira M; Satoh H; Miki A; Hori S; Sawada Y
    Cancer Chemother Pharmacol; 2010 Oct; 66(5):969-72. PubMed ID: 20107800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot study of a novel patient self-management program for warfarin therapy using venipuncture-acquired international normalized ratio monitoring.
    Simmons BJ; Jenner KM; Delate T; Clark NP; Kurz D; Witt DM
    Pharmacotherapy; 2012 Dec; 32(12):1078-84. PubMed ID: 23112110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computer-aided dosage in oral anticoagulation therapy using phenprocoumon. Problems and approaches.
    Cromme L; Völler H; Gäbler F; Salzwedel A; Taborski U
    Hamostaseologie; 2010 Nov; 30(4):183-9. PubMed ID: 21057712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP2C9 genotypes and dose requirements during the induction phase of oral anticoagulant therapy.
    Peyvandi F; Spreafico M; Siboni SM; Moia M; Mannucci PM
    Clin Pharmacol Ther; 2004 Mar; 75(3):198-203. PubMed ID: 15001971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic quality control of oral anticoagulant therapy comparing the short-acting acenocoumarol and the long-acting phenprocoumon.
    Gadisseur AP; van der Meer FJ; Adriaansen HJ; Fihn SD; Rosendaal FR
    Br J Haematol; 2002 Jun; 117(4):940-6. PubMed ID: 12060134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.